Shucheng Hua Selected Research

Cadherins (E-Cadherin)

1/2016

Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shucheng Hua Research Topics

Disease

14	Neoplasms (Cancer) 01/2024 - 06/2010
10	Inflammation (Inflammations) 05/2024 - 04/2011
9	Asthma (Bronchial Asthma) 05/2024 - 04/2011
6	Lung Neoplasms (Lung Cancer) 01/2021 - 06/2010
5	Infections 12/2022 - 05/2018
4	Pneumonia (Pneumonitis) 12/2018 - 09/2010
3	Respiratory Hypersensitivity 05/2024 - 02/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 01/2019
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023 - 10/2022
2	COVID-19 12/2022 - 10/2022
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 01/2022
2	Carcinogenesis 08/2021 - 06/2015
2	Acute Lung Injury 01/2019 - 01/2017
2	Triple Negative Breast Neoplasms 01/2017 - 01/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2016 - 07/2015
2	Breast Neoplasms (Breast Cancer) 01/2016 - 06/2015
1	Melanoma (Melanoma, Malignant) 11/2023
1	Tertiary Lymphoid Structures 09/2023
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Hyperplasia 04/2021
1	Respiratory Syncytial Virus Infections 10/2020
1	Adenocarcinoma of Lung 01/2020
1	Heart Injuries 10/2019
1	Myocarditis (Carditis) 10/2019
1	Communicable Diseases (Infectious Diseases) 12/2018
1	Bites and Stings (Sting) 01/2018

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
6	Interferon Regulatory FactorsIBA 10/2019 - 01/2017
5	CytokinesIBA 12/2018 - 07/2014
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
4	RNA (Ribonucleic Acid)IBA 11/2023 - 06/2015
4	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 01/2018
4	Interleukin-6 (Interleukin 6)IBA 10/2019 - 01/2017
3	OvalbuminIBA 05/2024 - 04/2011
3	CateninsIBA 08/2021 - 06/2015
3	InterleukinsIBA 04/2021 - 07/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2019 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 05/2018
2	GlucocorticoidsIBA 01/2024 - 04/2021
2	Messenger RNA (mRNA)IBA 09/2021 - 05/2018
2	Interferon-gamma (Interferon, gamma)IBA 04/2021 - 05/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2016
2	Interleukin-10 (Interleukin 10)IBA 12/2020 - 05/2018
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2017
2	OligodeoxyribonucleotidesIBA 05/2017 - 01/2017
2	Epidermal Growth Factor (EGF)IBA 01/2017 - 01/2016
2	Small Interfering RNA (siRNA)IBA 06/2015 - 04/2011
2	Interleukin-23 (Interleukin 23)IBA 07/2014 - 04/2011
2	Interleukin-17 (Interleukin 17)IBA 07/2014 - 04/2011
1	Ligases (Synthetase)IBA 05/2024
1	InflammasomesIBA 05/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Competitive Endogenous RNAIBA 01/2024
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2023
1	Cisplatin (Platino)FDA LinkGeneric 10/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2023
1	AntibodiesIBA 09/2023
1	Immunoglobulin M (IgM)IBA 09/2023
1	Immunoglobulin G (IgG)IBA 09/2023
1	Synthetic DrugsIBA 01/2023
1	DNA-Activated Protein KinaseIBA 12/2022
1	Caffeine (No Doz)FDA LinkGeneric 12/2022
1	Nucleic AcidsIBA 12/2022
1	SteroidsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	LipidsIBA 01/2022
1	MucinsIBA 09/2021
1	SuspensionsIBA 09/2021
1	matrigelIBA 08/2021
1	Myosin-Light-Chain PhosphataseIBA 08/2021
1	Sincalide FDA Link 08/2021
1	zingeroneIBA 04/2021
1	Interleukin-5 (Interleukin 5)IBA 04/2021
1	Interleukin-13IBA 04/2021
1	AMP-Activated Protein KinasesIBA 04/2021
1	CamptothecinIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2020
1	GTP-Binding Proteins (G-Protein)IBA 10/2020
1	GTP Phosphohydrolases (GTPases)IBA 10/2020
1	Caspase 3 (Caspase-3)IBA 09/2020
1	benzoylcarbonyl- aspartyl- glutamyl- valyl- aspartyl- fluoromethyl ketoneIBA 09/2020
1	Salmeterol Xinafoate (Serevent)FDA Link 04/2020
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 04/2020
1	indacaterolIBA 04/2020
1	Fluticasone (Cutivate)FDA LinkGeneric 04/2020
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 04/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Toll-Like Receptor 9IBA 10/2019
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 01/2019
1	Interferon Type IIBA 05/2018
1	Janus KinasesIBA 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2018

Therapy/Procedure

8	Therapeutics 01/2023 - 09/2010
1	Radiotherapy 01/2022